Staff Profile
Dr Mahsa Azizyan
Research Associate
- Email: mahsa.azizyan1@ncl.ac.uk
- Address: Newcastle University Biosciences Institute
2nd Floor Catherine Cookson Building
The Medical School
Newcastle University
NE2 4HH
Background
Education
PhD Newcastle University
MSc Cancer Biology, The University of Manchester
BSc (Hons) Biomedical Sciences, Newcastle University
Awards
The British Association for Cancer Research (BACR) Travel Fund - 2016
Newcastle University Travel Fund - 2016
Prostate Cancer UK Bursary - 2014
Cancer Research UK PhD studentship - 2012
Teaching
Invited Lecturer in Pharmacology
Supervision of undergraduate and postgraduate students
Seminar Leader in Biomedical Sciences and Pharmacology
Exam marker
Publications
-
Articles
- Alebady ZAH, Azizyan M, Nakjang S, Lishman-Walker E, Al-Kharaif D, Walker S, Choo HX, Garnham R, Scott E, Johnson KL, Robson CN, Coffey K. CDC20 is regulated by the histone methyltransferase, KMT5A, in castration resistant prostate cancer. Cancers 2023, 15(14), 3597.
- McClurg UL, Azizyan M, Dransfield DT, Namdev N, Chit NCTH, Nakjang S, Robson CN. The novel anti-androgen candidate galeterone targets deubiquitinating enzymes, USP12 and USP46, to control prostate cancer growth and survival. Oncotarget 2018, 9(38), 24992-25007.
- McClurg UL, Chit NCTH, Azizyan M, Edwards J, Nabbi A, Riabowol KT, Nakjang S, McCracken SR, Robson CN. Molecular mechanism of the TP53-MDM2-AR-AKT signalling network regulation by USP12. Oncogene 2018, 37, 4679-4691.
- Honeychurch J, Alduaij W, Azizyan M, Cheadle EJ, Pelicano H, Ivanov A, Huang P, Cragg MS, Illidge TM. Antibody-induced nonapoptotic cell death in human lymphoma and leukemia cells is mediated through a novel reactive oxygen species-dependent pathway. Blood 2012, 119(15), 3523-3533.
-
Conference Proceedings (inc. Abstract)
- Azizyan M, Coffey K, Robson CN. The role of KMT5A in prostate cancer. In: American Association for Cancer Research Annual Meeting. 2016, New Orleans.